Your browser doesn't support javascript.
loading
Proposed Best Practice Guidelines for Scientific Response Documents: A Consensus Statement from phactMI.
Hermes-DeSantis, Evelyn R; Johnson, Renee M; Redlich, Alysa; Patel, Bindi; Flanigan-Minnick, Anne; Wnorowski, Susan; Cortes, Mabel M; Han, Chang Woo; Vine, Elissa; Sarwar, Hamza; Haydar, Rita; Jamil, Ahsan; Huang, Tiffany; Sandhu, Sonia Kaur; Reilly, Patrick.
Afiliação
  • Hermes-DeSantis ER; Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy, Rutgers The State University of New Jersey, 160 Frelinghuysen Rd, Piscataway, NJ, 08854, USA. evelyn@phactmi.org.
  • Johnson RM; Global Medical Information, Pfizer, 500 Arcola Rd, Collegeville, PA, 19426, USA.
  • Redlich A; Global Medical Information, Biogen, 225 Binney Street, Cambridge, MA, 02142, USA.
  • Patel B; Medical Affairs Communications, Bayer Healthcare Pharmaceuticals Inc., 100 Bayer Blvd, Whippany, NJ, 07981, USA.
  • Flanigan-Minnick A; Global Medical Information, Merck & Co., Inc., 351 N. Sumneytown Pike, MS UG1B-50, North Wales, PA, 19454, USA.
  • Wnorowski S; US Medical Information, Ipsen US Medical Affairs Division, 106 Allen Rd, Basking Ridge, NJ, 07920, USA.
  • Cortes MM; Global Medical Scientific Information, Allergan, 100 Somerset Corporate Blvd, Bridgewater Township, NJ, 08807, USA.
  • Han CW; US Medical Affairs, Bristol-Myers Squibb, 86 Morris Ave., Summit, NJ, 07901, USA.
  • Vine E; Medical Information and Knowledge Integration, Janssen, 00 Tournament Dr, Horsham, PA, 19044, USA.
  • Sarwar H; Global Medical Information, Sanofi, 55 Corporate Dr, Bridgewater Township, NJ, 08807, USA.
  • Haydar R; Knowledge-Centered Capabilities, Eli Lilly and Company, 893 Delaware St, Indianapolis, IN, 46225, USA.
  • Jamil A; Medical Information, Sandoz, 100 College Rd W, Princeton, NJ, 08540, USA.
  • Huang T; Medical Information, Gilead Sciences, 333 Lakeside Dr, Foster City, CA, 94404, USA.
  • Sandhu SK; Medical Information, Gilead Sciences, 333 Lakeside Dr, Foster City, CA, 94404, USA.
  • Reilly P; PhactMI, PO Box 320, West Point, PA, 19486, USA.
Ther Innov Regul Sci ; 54(6): 1303-1311, 2020 11.
Article em En | MEDLINE | ID: mdl-33258092
ABSTRACT
The Medical Information Department of a pharmaceutical manufacturer provides written scientific responses to unsolicited requests from healthcare providers for information on products that extends beyond the product labeling (off-label). These scientific response documents are non-promotional, evidence-based, and scientifically balanced, conforming with internal pharmaceutical manufacturer's procedures and the Food and Drug Administration (FDA) Draft Guidance on Responding to Unsolicited Requests for Off-Label Information. Members of phactMI™ developed this proposal to offer best practices for content generation of scientific response documents. Scientific response documents review available literature to respond to an unsolicited request; therefore, they are similar in nature to systematic reviews. The sections and elements identified in this proposed best practice guidelines for scientific response documents are based on an adaptation of the sections and elements of systematic reviews. The sections of a scientific response document should include a restatement of the unsolicited request (title); a structured summary (abstract); approved indications, black box warnings, and background information when appropriate (introduction); the literature search information and study selection (methods); summation of data from clinical trials, meta-analysis, case reports, and/or real world evidence, as appropriate (results); treatment guidelines, if applicable and available (discussion); and references. Elements for each section should be included in a scientific response document as appropriate, as some elements are not necessary in some documents, based on the question. These elements were selected for inclusion to address any potential concerns of bias and transparency and reflect the intent that scientific response documents should be non-promotional, accurate, truthful, free of commercial bias, scientifically balanced, and evidence based.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Preparações Farmacêuticas Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Preparações Farmacêuticas Idioma: En Ano de publicação: 2020 Tipo de documento: Article